Drug Trial Radar · NCT07405554
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
Last checked: Nov 20, 2026Latest source record: Jul 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Feb 26, 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Endeavor HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 21 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized, double-blind, placebo-controlled trial evaluates whether oral zinc plus phytase supplementation modifies clinical response to intradetrusor botulinum toxin injection in patients with overactive bladder. Participants will receive either zinc plus phytase supplementation or matching placebo for five days prior to intradetrusor botulinum toxin injection. Participants will be followed for six months after treatment to assess need for repeat botulinum toxin injection, urinary symptoms, and patient-reported outcomes related to overactive bladder.
Conditions
- Overactive Bladder (OAB)
Interventions
Zinc Citrate Oral CapsuleDrug
Zinc citrate 50mg combined with 7,500 phytase units in an oral capsule
PlaceboDrug
Placebo oral capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients needing repeat intradetrusor botulinum toxin injection at 6 monthsTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Endeavor Health
Skokie, Illinois · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.